A Phase I/II Trial Of ZD1839 (Iressa) [gefitinib] And Radiation In Pediatric Patients Newly Diagnosed With Brain Stem Tumors Or Incompletely Resected Supratentorial Malignant Gliomas With Phase II Limited To Brain Stem Tumors
Latest Information Update: 03 Nov 2021
At a glance
- Drugs Gefitinib (Primary)
- Indications Anaplastic astrocytoma; Brain cancer; Glioblastoma; Glioma
- Focus Therapeutic Use
- 23 Sep 2010 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov record.
- 07 Sep 2006 Status change
- 07 Sep 2005 New trial record.